{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:54:10Z","timestamp":1793858050591,"version":"4.6.1"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Over recent years, mesenchymal stem\/stromal cells (MSCs) and their potential biomedical applications have received much attention from the global scientific community in an increasing manner. Firstly, MSCs were successfully isolated from human bone marrow (BM), but in the next steps, they were also extracted from other sources, mostly from the umbilical cord (UC) and adipose tissue (AT). The International Society for Cellular Therapy (ISCT) has suggested minimum criteria to identify and characterize MSCs as follows: plastic adherence, surface expression of CD73, D90, CD105 in the lack of expression of CD14, CD34, CD45, and human leucocyte antigen-DR (HLA-DR), and also the capability to differentiate to multiple cell types including adipocyte, chondrocyte, or osteoblast in vitro depends on culture conditions. However, these distinct properties, including self-renewability, multipotency, and easy accessibility are just one side of the coin; another side is their huge secretome which is comprised of hundreds of mediators, cytokines, and signaling molecules and can effectively modulate the inflammatory responses and control the infiltration process that finally leads to a regulated tissue repair\/healing or regeneration process. MSC-mediated immunomodulation is a direct result of a harmonic synergy of MSC-released signaling molecules (i.e., mediators, cytokines, and chemokines), the reaction of immune cells and other target cells to those molecules, and also feedback in the MSC-molecule-target cell axis. These features make MSCs a respectable and eligible therapeutic candidate to be evaluated in immune-mediated disorders, such as graft versus host diseases (GVHD), multiple sclerosis (MS), Crohn\u2019s disease (CD), and osteoarthritis (OA), and even in immune-dysregulating infectious diseases such as the novel coronavirus disease 2019 (COVID-19). This paper discussed the therapeutic applications of MSC secretome and its biomedical aspects related to immune-mediated conditions. Sources for MSC extraction, their migration and homing properties, therapeutic molecules released by MSCs, and the pathways and molecular mechanisms possibly involved in the exceptional immunoregulatory competence of MSCs were discussed. Besides, the novel discoveries and recent findings on immunomodulatory plasticity of MSCs, clinical applications, and the methods required for their use as an effective therapeutic option in patients with immune-mediated\/immune-dysregulating diseases were highlighted.<\/jats:p>","DOI":"10.1186\/s13287-021-02265-1","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T19:13:08Z","timestamp":1616094788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":222,"title":["RETRACTED ARTICLE: Mesenchymal stem\/stromal cells as a valuable source for the treatment of immune-mediated disorders"],"prefix":"10.1186","volume":"12","author":[{"given":"Alexander","family":"Markov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Thangavelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendar","family":"Aravindhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina Olegovna","family":"Zekiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Jarahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max Stanley","family":"Chartrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashwant","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faroogh","family":"Marofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Shamlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"2265_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3727\/096368910X","volume":"20","author":"D-C Ding","year":"2011","unstructured":"Ding D-C, Shyu W-C, Lin S-Z. Mesenchymal stem cells. Cell Transplant. 2011;20:5\u201314.","journal-title":"Cell Transplant"},{"key":"2265_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1242\/dev.16.3.381","volume":"16","author":"A Friedenstein","year":"1966","unstructured":"Friedenstein A, Piatetzky-Shapiro I, Petrakova K. Osteogenesis in transplants of bone marrow cells. Development. 1966;16:381\u201390.","journal-title":"Development"},{"key":"2265_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2478\/acb-2020-0010","volume":"8","author":"K Stefa\u0144ska","year":"2020","unstructured":"Stefa\u0144ska K, Bryl R, Moncrieff L, Pinto N, Shibli JA, Dyszkiewicz-Konwi\u0144ska M. Mesenchymal stem cells\u2013a historical overview. Med J Cell Biol. 2020;8:83\u20137.","journal-title":"Med J Cell Biol"},{"key":"2265_CR4","doi-asserted-by":"publisher","first-page":"9185","DOI":"10.1002\/jcp.29803","volume":"235","author":"S Tavakoli","year":"2020","unstructured":"Tavakoli S, Ghaderi Jafarbeigloo HR, Shariati A, Jahangiryan A, Jadidi F, Jadidi Kouhbanani MA, Hassanzadeh A, Zamani M, Javidi K, Naimi A. Mesenchymal stromal cells; a new horizon in regenerative medicine. J Cell Physiol. 2020;235:9185\u2013210.","journal-title":"J Cell Physiol"},{"key":"2265_CR5","first-page":"208","volume":"10","author":"K Baghaei","year":"2017","unstructured":"Baghaei K, Hashemi SM, Tokhanbigli S, Asadi Rad A, Assadzadeh-Aghdaei H, Sharifian A, Zali MR. Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. Gastroenterol Hepatol Bed Bench. 2017;10:208\u201313.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2265_CR6","doi-asserted-by":"publisher","first-page":"6901983","DOI":"10.1155\/2018\/6901983","volume":"2018","author":"MS Hu","year":"2018","unstructured":"Hu MS, Borrelli MR, Lorenz HP, Longaker MT, Wan DC. Mesenchymal stromal cells and cutaneous wound healing: a comprehensive review of the background, role, and therapeutic potential. Stem Cells Int. 2018;2018:6901983.","journal-title":"Stem Cells Int"},{"key":"2265_CR7","doi-asserted-by":"crossref","unstructured":"Samadi P, Saki S, Khoshinani HM, Sheykhhasan M. Therapeutic applications of mesenchymal stem cells: a comprehensive review. Curr Stem Cell Res Ther. 2020;","DOI":"10.2174\/1574888XMTA5bOTEh1"},{"key":"2265_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","volume-title":"Mesenchymal Stem Cells","author":"M Gnecchi","year":"2016","unstructured":"Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. In: Mesenchymal Stem Cells: Springer; 2016. p. 123\u201346."},{"key":"2265_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/biof.1374","volume":"43","author":"V Volarevic","year":"2017","unstructured":"Volarevic V, Gazdic M, Markovic BS, Jovicic N, Djonov V, Arsenijevic N. Mesenchymal stem cell-derived factors: immuno-modulatory effects and therapeutic potential. Biofactors (Oxford, England). 2017;43:633\u201344.","journal-title":"Biofactors (Oxford, England)"},{"key":"2265_CR10","doi-asserted-by":"publisher","first-page":"15108","DOI":"10.1002\/jcp.28152","volume":"234","author":"F Marofi","year":"2019","unstructured":"Marofi F, Hassanzadeh A, Solali S, Vahedi G, Mousavi Ardehaie R, Salarinasab S, Aliparasti MR, Ghaebi M, Farshdousti Hagh M. Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: the role of zoledronic acid on tuning the epigenetic changes. J Cell Physiol. 2019;234:15108\u201322.","journal-title":"J Cell Physiol"},{"key":"2265_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/scd.2009.0345","volume":"19","author":"S Zhao","year":"2010","unstructured":"Zhao S, Wehner R, Bornh\u00e4user M, Wassmuth R, Bachmann M, Schmitz M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev. 2010;19:607\u201314.","journal-title":"Stem Cells Dev"},{"key":"2265_CR12","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.jid.2017.02.986","volume":"137","author":"JY Lim","year":"2017","unstructured":"Lim JY, Ryu DB, Lee SE, Park G, Min CK. Mesenchymal stem cells (MSCs) attenuate cutaneous sclerodermatous graft-versus-host disease (Scl-GVHD) through inhibition of immune cell infiltration in a mouse model. J Invest Dermatol. 2017;137:1895\u2013904.","journal-title":"J Invest Dermatol"},{"key":"2265_CR13","doi-asserted-by":"crossref","unstructured":"Gnecchi M, Ciuffreda MC, Mura M. Mesenchymal stromal cell secretome for tissue repair. Cell Eng Regen. 2020:641\u201366.","DOI":"10.1007\/978-3-319-08831-0_43"},{"key":"2265_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jcyt.2018.09.008","volume":"20","author":"WS Toh","year":"2018","unstructured":"Toh WS, Zhang B, Lai RC, Lim SK. Immune regulatory targets of mesenchymal stromal cell exosomes\/small extracellular vesicles in tissue regeneration. Cytotherapy. 2018;20:1419\u201326.","journal-title":"Cytotherapy"},{"key":"2265_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fbioe.2019.00352","volume":"7","author":"D Marolt Presen","year":"2019","unstructured":"Marolt Presen D, Traweger A, Gimona M, Redl H. Mesenchymal stromal\/stem cell-based bone regeneration therapies: from cell transplantation and tissue engineering to therapeutic secretomes and extracellular vesicles. Front Bioeng Biotechnol. 2019;7:352.","journal-title":"Front Bioeng Biotechnol"},{"key":"2265_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/jcm8071025","volume":"8","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Yamamoto Y, Xiao Z, Ochiya T. The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity. J Clin Med. 2019;8:1025.","journal-title":"J Clin Med"},{"key":"2265_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-9-9","volume":"9","author":"C L\u00e4sser","year":"2011","unstructured":"L\u00e4sser C, Alikhani VS, Ekstr\u00f6m K, Eldh M, Paredes PT, Bossios A, Sj\u00f6strand M, Gabrielsson S, L\u00f6tvall J, Valadi H. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011;9:1\u20138.","journal-title":"J Transl Med"},{"key":"2265_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrurol.2014.301","volume":"11","author":"M Nawaz","year":"2014","unstructured":"Nawaz M, Camussi G, Valadi H, Nazarenko I, Ekstr\u00f6m K, Wang X, Principe S, Shah N, Ashraf NM, Fatima F. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol. 2014;11:688.","journal-title":"Nat Rev Urol"},{"key":"2265_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/epr.09.17","volume":"6","author":"RJ Simpson","year":"2009","unstructured":"Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics. 2009;6:267\u201383.","journal-title":"Expert Rev Proteomics"},{"key":"2265_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373\u201383.","journal-title":"J Cell Biol"},{"key":"2265_CR21","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/jcp.27152","volume":"234","author":"F Marofi","year":"2019","unstructured":"Marofi F, Vahedi G, Hasanzadeh A, Salarinasab S, Arzhanga P, Khademi B, Farshdousti Hagh M. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: mirage or reality? J Cell Physiol. 2019;234:1268\u201388.","journal-title":"J Cell Physiol"},{"key":"2265_CR22","first-page":"188","volume":"20","author":"M Ahani-Nahayati","year":"2018","unstructured":"Ahani-Nahayati M, Solali S, Shams Asenjan K, Movassaghpour Akbari AA, Talebi M, Zadi Heydarabad M, Baharaghdam S, Farshdousti Hagh M. Promoter methylation status of survival-related genes in MOLT- 4 cells co-cultured with bone marrow mesenchymal stem cells under hypoxic conditions. Cell J. 2018;20:188\u201394.","journal-title":"Cell J"},{"key":"2265_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cyto.a.23242","volume":"93","author":"D Mushahary","year":"2018","unstructured":"Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytom Part A. 2018;93:19\u201331.","journal-title":"Cytom Part A"},{"key":"2265_CR24","doi-asserted-by":"publisher","first-page":"151097","DOI":"10.1016\/j.ejcb.2020.151097","volume":"99","author":"A Shariati","year":"2020","unstructured":"Shariati A, Nemati R, Sadeghipour Y, Yaghoubi Y, Baghbani R, Javidi K, Zamani M, Hassanzadeh A. Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier. Eur J Cell Biol. 2020;99:151097.","journal-title":"Eur J Cell Biol"},{"key":"2265_CR25","doi-asserted-by":"crossref","unstructured":"Fan X-L, Zhang Y, Li X, Fu Q-L. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020:77;1\u201324.","DOI":"10.1007\/s00018-020-03454-6"},{"key":"2265_CR26","doi-asserted-by":"publisher","first-page":"17986","DOI":"10.3390\/ijms140917986","volume":"14","author":"HJ Jin","year":"2013","unstructured":"Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, Kim SW, Yang YS, Oh W, Chang JW. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14:17986\u20138001.","journal-title":"Int J Mol Sci"},{"key":"2265_CR27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/jcb.25395","volume":"117","author":"YJ Jeon","year":"2016","unstructured":"Jeon YJ, Kim J, Cho JH, Chung HM, Chae JI. Comparative analysis of human mesenchymal stem cells derived from bone marrow, placenta, and adipose tissue as sources of cell therapy. J Cell Biochem. 2016;117:1112\u201325.","journal-title":"J Cell Biochem"},{"key":"2265_CR28","doi-asserted-by":"crossref","unstructured":"Konala VBR, Bhonde R, Pal R. Secretome studies of mesenchymal stromal cells (MSCs) isolated from three tissue sources reveal subtle differences in potency. In Vitro Cell Dev Biol Anim. 2020:56;1\u201312.","DOI":"10.1007\/s11626-020-00501-1"},{"key":"2265_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/21645515.2015.1030549","volume":"12","author":"Q Wang","year":"2016","unstructured":"Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F, Meng Y, Yuan Z. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Wharton\u2019s jelly as sources of cell immunomodulatory therapy. Hum Vaccin Immunother. 2016;12:85\u201396.","journal-title":"Hum Vaccin Immunother"},{"key":"2265_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/03008200701228464","volume":"48","author":"M Bernardo","year":"2007","unstructured":"Bernardo M, Emons J, Karperien M, Nauta A, Willemze R, Roelofs H, Romeo S, Marchini A, Rappold G, Vukicevic S. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res. 2007;48:132\u201340.","journal-title":"Connect Tissue Res"},{"key":"2265_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13578-019-0281-3","volume":"9","author":"C Shen","year":"2019","unstructured":"Shen C, Yang C, Xu S, Zhao H. Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC). Cell Biosci. 2019;9:17.","journal-title":"Cell Biosci"},{"key":"2265_CR32","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8:886.","journal-title":"Cells"},{"key":"2265_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2337\/db08-0180","volume":"57","author":"R Abdi","year":"2008","unstructured":"Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 2008;57:1759\u201367.","journal-title":"Diabetes"},{"key":"2265_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.immuni.2006.07.012","volume":"25","author":"JC Marie","year":"2006","unstructured":"Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-\u03b2 receptor. Immunity. 2006;25:441\u201354.","journal-title":"Immunity"},{"key":"2265_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biomaterials.2014.11.020","volume":"41","author":"MD Swartzlander","year":"2015","unstructured":"Swartzlander MD, Blakney AK, Amer LD, Hankenson KD, Kyriakides TR, Bryant SJ. Immunomodulation by mesenchymal stem cells combats the foreign body response to cell-laden synthetic hydrogels. Biomaterials. 2015;41:79\u201388.","journal-title":"Biomaterials"},{"key":"2265_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/asj\/sjv231","volume":"36","author":"G Rigotti","year":"2016","unstructured":"Rigotti G, Charles-de-S\u00e1 L, Gontijo-de-Amorim NF, Takiya CM, Amable PR, Borojevic R, Benati D, Bernardi P, Sbarbati A. Expanded stem cells, stromal-vascular fraction, and platelet-rich plasma enriched fat: comparing results of different facial rejuvenation approaches in a clinical trial. Aesthet Surg J. 2016;36:261\u201370.","journal-title":"Aesthet Surg J"},{"key":"2265_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fcvm.2017.00032","volume":"4","author":"F Li","year":"2017","unstructured":"Li F, Guo X, Chen S-Y. Function and therapeutic potential of mesenchymal stem cells in atherosclerosis. Front Cardiovasc Med. 2017;4:32.","journal-title":"Front Cardiovasc Med"},{"key":"2265_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P, Kurte M, Bravo-Alegr\u00eda J, Contreras R, Nova-Lamperti E, Tejedor G, No\u00ebl D, Jorgensen C, Figueroa F, Djouad F, Carri\u00f3n F. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013;4:65.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR39","doi-asserted-by":"crossref","unstructured":"Salah RB, Snoussi M, Louati N, Donia C, Frikha F, Hela M, Zouhir B. The lymphoproliferative auto-immune syndrome: a rare cause of peripheral cytopenia. Electron J Gen Med. 2018:5;15.","DOI":"10.29333\/ejgm\/94112"},{"key":"2265_CR40","doi-asserted-by":"publisher","first-page":"em00724","DOI":"10.5799\/jcei\/5833","volume":"10","author":"EG Umit","year":"2019","unstructured":"Umit EG, Baysal M, Bas V, Goze H, Asoglu V, Kirkizlar O, Demir AM. Value of extracellular high mobility group box 1 (HMGB1) in the clinical context of immune thrombocytopenia. J Clin Exp Invest. 2019;10:em00724.","journal-title":"J Clin Exp Invest"},{"key":"2265_CR41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/leu.2010.310","volume":"25","author":"R Meisel","year":"2011","unstructured":"Meisel R, Brockers S, Heseler K, Degistirici \u00d6, B\u00fclle H, Woite C, Stuhlsatz S, Schwippert W, J\u00e4ger M, Sorg R. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2, 3-dioxygenase. Leukemia. 2011;25:648\u201354.","journal-title":"Leukemia"},{"key":"2265_CR42","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.kint.2017.08.030","volume":"93","author":"M Bai","year":"2018","unstructured":"Bai M, Zhang L, Fu B, Bai J, Zhang Y, Cai G, Bai X, Feng Z, Sun S, Chen X. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2\/PGE2 pathway. Kidney Int. 2018;93:814\u201325.","journal-title":"Kidney Int"},{"key":"2265_CR43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","volume":"25","author":"G Wang","year":"2018","unstructured":"Wang G, Cao K, Liu K, Xue Y, Roberts AI, Li F, Han Y, Rabson AB, Wang Y, Shi Y. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25:1209\u201323.","journal-title":"Cell Death Differ"},{"key":"2265_CR44","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1126\/science.1172638","volume":"324","author":"MS Sundrud","year":"2009","unstructured":"Sundrud MS, Koralov SB, Feuerer M, Calado DP, Kozhaya AE, Rhule-Smith A, Lefebvre RE, Unutmaz D, Mazitschek R, Waldner H. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science (New York, N.Y.). 2009;324:1334\u20138.","journal-title":"Science (New York, N.Y.)"},{"key":"2265_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.humimm.2012.12.011","volume":"74","author":"Y-z Gu","year":"2013","unstructured":"Gu Y-z, Xue Q, Chen Y-j, Yu G-H, Shen Y, Wang M-y, Shi Q, Zhang X-G. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells. Hum Immunol. 2013;74:267\u201376.","journal-title":"Hum Immunol"},{"key":"2265_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.imlet.2014.09.013","volume":"162","author":"Z Yan","year":"2014","unstructured":"Yan Z, Zhuansun Y, Liu G, Chen R, Li J, Ran P. Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1\/B7-H1 interactions. Immunol Lett. 2014;162:248\u201355.","journal-title":"Immunol Lett"},{"key":"2265_CR47","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.intimp.2014.03.003","volume":"20","author":"A Mohammadzadeh","year":"2014","unstructured":"Mohammadzadeh A, Pourfathollah AA, Shahrokhi S, Hashemi SM, Moradi SLA, Soleimani M. Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets. Int Immunopharmacol. 2014;20:316\u201321.","journal-title":"Int Immunopharmacol"},{"key":"2265_CR48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523\u201332.","journal-title":"Nat Rev Immunol"},{"key":"2265_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.immuni.2006.07.011","volume":"25","author":"MO Li","year":"2006","unstructured":"Li MO, Sanjabi S, Flavell RA. Transforming growth factor-\u03b2 controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity. 2006;25:455\u201371.","journal-title":"Immunity"},{"key":"2265_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1189\/jlb.3A0513-242R","volume":"96","author":"PM Chen","year":"2014","unstructured":"Chen PM, Liu KJ, Hsu PJ, Wei CF, Bai CH, Ho LJ, Sytwu HK, Yen BL. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1\/2. J Leukoc Biol. 2014;96:295\u2013303.","journal-title":"J Leukoc Biol"},{"key":"2265_CR51","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1378\/chest.14-1194","volume":"146","author":"PJ Barnes","year":"2014","unstructured":"Barnes PJ. Hepatocyte growth factor deficiency in COPD: a mechanism of emphysema and small airway fibrosis? Chest. 2014;146:1135\u20136.","journal-title":"Chest"},{"key":"2265_CR52","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"ARR Weiss","year":"2019","unstructured":"Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1191.","journal-title":"Front Immunol"},{"key":"2265_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.15283\/ijsc.2015.8.1.54","volume":"8","author":"N Kim","year":"2015","unstructured":"Kim N, Cho S-G. New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells. 2015;8:54\u201368.","journal-title":"Int J Stem Cells"},{"key":"2265_CR54","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76:3323\u201348.","journal-title":"Cell Mol Life Sci"},{"key":"2265_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","volume":"15","author":"M Ullah","year":"2019","unstructured":"Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. 2019;15:421\u201338.","journal-title":"iScience"},{"key":"2265_CR56","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","volume":"25","author":"AL Ponte","year":"2007","unstructured":"Ponte AL, Marais E, Gallay N, Langonn\u00e9 A, Delorme B, H\u00e9rault O, Charbord P, Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737\u201345.","journal-title":"Stem Cells"},{"key":"2265_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.carrev.2005.10.008","volume":"7","author":"S Bhakta","year":"2006","unstructured":"Bhakta S, Hong P, Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med. 2006;7:19\u201324.","journal-title":"Cardiovasc Revasc Med"},{"key":"2265_CR58","doi-asserted-by":"crossref","unstructured":"Pourjafar M, Saidijam M, Mansouri K, Ghasemibasir H, Karimi Dermani F, Najafi R. All-trans retinoic acid preconditioning enhances proliferation, angiogenesis and migration of mesenchymal stem cell in vitro and enhances wound repair in vivo. Cell Prolif. 2017:50;50.","DOI":"10.1111\/cpr.12315"},{"key":"2265_CR59","doi-asserted-by":"publisher","first-page":"9529465","DOI":"10.1155\/2020\/9529465","volume":"2020","author":"M Hassan","year":"2020","unstructured":"Hassan M, Yazid MD, Yunus MHM, Chowdhury SR, Lokanathan Y, Idrus RBH, Ng AMH, Law JX. Large-scale expansion of human mesenchymal stem cells. Stem Cells Int. 2020;2020:9529465.","journal-title":"Stem Cells Int"},{"key":"2265_CR60","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2014.00148","volume":"5","author":"E Eggenhofer","year":"2014","unstructured":"Eggenhofer E, Luk F, Dahlke MH, Hoogduijn MJ. The life and fate of mesenchymal stem cells. Front Immunol. 2014;5:148.","journal-title":"Front Immunol"},{"key":"2265_CR61","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1634\/stemcells.2004-0330","volume":"23","author":"T Tondreau","year":"2005","unstructured":"Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005;23:1105\u201312.","journal-title":"Stem Cells"},{"key":"2265_CR62","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/jor.21167","volume":"28","author":"JJ Alm","year":"2010","unstructured":"Alm JJ, Koivu HM, Heino TJ, Hentunen TA, Laitinen S, Aro HT. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res. 2010;28:1634\u201342.","journal-title":"J Orthop Res"},{"key":"2265_CR63","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1634\/stemcells.2006-0164","volume":"24","author":"GY Rochefort","year":"2006","unstructured":"Rochefort GY, Delorme B, Lopez A, H\u00e9rault O, Bonnet P, Charbord P, Eder V, Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. 2006;24:2202\u20138.","journal-title":"Stem Cells"},{"key":"2265_CR64","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1582-4934.2009.00912.x","volume":"14","author":"Y Chen","year":"2010","unstructured":"Chen Y, Xiang LX, Shao JZ, Pan RL, Wang YX, Dong XJ, Zhang GR. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J Cell Mol Med. 2010;14:1494\u2013508.","journal-title":"J Cell Mol Med"},{"key":"2265_CR65","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/stem.1375","volume":"31","author":"M Gil-Ortega","year":"2013","unstructured":"Gil-Ortega M, Garidou L, Barreau C, Maumus M, Breasson L, Tavernier G, Garc\u00eda-Prieto CF, Bouloumi\u00e9 A, Casteilla L, Sengen\u00e8s C. Native adipose stromal cells egress from adipose tissue in vivo: evidence during lymph node activation. Stem Cells. 2013;31:1309\u201320.","journal-title":"Stem Cells"},{"key":"2265_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/7651_2019_271","volume-title":"Multifunctional magnetic nanoparticles-labeled mesenchymal stem cells for hyperthermia and bioimaging applications","author":"S Ghorbanzade","year":"2019","unstructured":"Ghorbanzade S, Naghib SM, Sadr A, Fateminia FS, Ghaffarinejad A, Majidzadeh-A K, Sanati-Nezhad A. Multifunctional magnetic nanoparticles-labeled mesenchymal stem cells for hyperthermia and bioimaging applications; 2019."},{"key":"2265_CR67","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cells8080784","volume":"8","author":"X Fu","year":"2019","unstructured":"Fu X, Liu G, Halim A, Ju Y, Luo Q, Song G. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8:784.","journal-title":"Cells"},{"key":"2265_CR68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3324\/haematol.10669","volume":"92","author":"M Shi","year":"2007","unstructured":"Shi M, Li J, Liao L, Chen B, Li B, Chen L, Jia H, Zhao RC. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD\/SCID mice. Haematologica. 2007;92:897\u2013904.","journal-title":"Haematologica"},{"key":"2265_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3760\/cma.j.issn.0366-6999.2009.02.014","volume":"122","author":"Y Zhuang","year":"2009","unstructured":"Zhuang Y, Chen X, Xu M, Zhang LY, Xiang F. Chemokine stromal cell-derived factor 1\/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chin Med J. 2009;122:183\u20137.","journal-title":"Chin Med J"},{"key":"2265_CR70","doi-asserted-by":"publisher","first-page":"I-38","DOI":"10.1161\/CIRCULATIONAHA.106.680231","volume":"116","author":"Y Amsalem","year":"2007","unstructured":"Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, Daniels D, Ocherashvilli A, Holbova R, Yosef O, Barbash IM. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007;116:I-38\u201345.","journal-title":"Circulation"},{"key":"2265_CR71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/1673-5374.224382","volume":"13","author":"AA Peyvandi","year":"2018","unstructured":"Peyvandi AA, Roozbahany NA, Peyvandi H, Abbaszadeh H-A, Majdinasab N, Faridan M, Niknazar S. Critical role of SDF-1\/CXCR4 signaling pathway in stem cell homing in the deafened rat cochlea after acoustic trauma. Neural Regen Res. 2018;13:154\u201360.","journal-title":"Neural Regen Res"},{"key":"2265_CR72","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1039\/C9BM00242A","volume":"7","author":"X Li","year":"2019","unstructured":"Li X, Wei Z, Li B, Li J, Lv H, Wu L, Zhang H, Yang B, Zhu M, Jiang J. In vivo migration of Fe 3 O 4@ polydopamine nanoparticle-labeled mesenchymal stem cells to burn injury sites and their therapeutic effects in a rat model. Biomater Sci. 2019;7:2861\u201372.","journal-title":"Biomater Sci"},{"key":"2265_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","volume":"8","author":"A De Becker","year":"2016","unstructured":"De Becker A, Van Riet I. Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy? World J Stem Cells. 2016;8:73.","journal-title":"World J Stem Cells"},{"key":"2265_CR74","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2217\/rme.12.82","volume":"7","author":"RC Rennert","year":"2012","unstructured":"Rennert RC, Sorkin M, Garg RK, Gurtner GC. Stem cell recruitment after injury: lessons for regenerative medicine. Regen Med. 2012;7:833\u201350.","journal-title":"Regen Med"},{"key":"2265_CR75","first-page":"51","volume":"2","author":"KA Cho","year":"2009","unstructured":"Cho KA, Ju SY, Ryu KH, Woo SY. Gene expression profile of mesenchymal stromal cells after co-culturing with injured liver tissue. Mol Med Rep. 2009;2:51\u201361.","journal-title":"Mol Med Rep"},{"key":"2265_CR76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/stem.2759","volume":"36","author":"S Fujii","year":"2018","unstructured":"Fujii S, Miura Y, Fujishiro A, Shindo T, Shimazu Y, Hirai H, Tahara H, Takaori-Kondo A, Ichinohe T, Maekawa T. Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal\/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations. Stem Cells. 2018;36:434\u201345.","journal-title":"Stem Cells"},{"key":"2265_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jtos.2019.01.001","volume":"17","author":"R Mart\u00ednez-Carrasco","year":"2019","unstructured":"Mart\u00ednez-Carrasco R, S\u00e1nchez-Abarca LI, Nieto-G\u00f3mez C, Mart\u00edn Garc\u00eda E, S\u00e1nchez-Guijo F, Arg\u00fceso P, Aij\u00f3n J, Hern\u00e1ndez-Galilea E, Velasco A. Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD. Ocul Surf. 2019;17:285\u201394.","journal-title":"Ocul Surf"},{"key":"2265_CR78","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1159\/000489689","volume":"46","author":"B Tang","year":"2018","unstructured":"Tang B, Li X, Liu Y, Chen X, Li X, Chu Y, Zhu H, Liu W, Xu F, Zhou F, Zhang Y. The therapeutic effect of ICAM-1-overexpressing mesenchymal stem cells on acute graft-versus-host disease. Cell Physiol Biochem. 2018;46:2624\u201335.","journal-title":"Cell Physiol Biochem"},{"key":"2265_CR79","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3892\/etm.2017.4131","volume":"13","author":"S Ma","year":"2017","unstructured":"Ma S, Chen X, Wang L, Wei Y, Ni Y, Chu Y, Liu Y, Zhu H, Zheng R, Zhang Y. Repairing effects of ICAM-1-expressing mesenchymal stem cells in mice with autoimmune thyroiditis. Exp Ther Med. 2017;13:1295\u2013302.","journal-title":"Exp Ther Med"},{"key":"2265_CR80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.imlet.2012.01.015","volume":"143","author":"W Chen","year":"2012","unstructured":"Chen W, Li M, Li Z, Yan Z, Cheng H, Pan B, Cao J, Chen C, Zeng L, Xu K. CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. Immunol Lett. 2012;143:161\u20139.","journal-title":"Immunol Lett"},{"key":"2265_CR81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5483\/BMBRep.2016.49.6.056","volume":"49","author":"H-M Lee","year":"2016","unstructured":"Lee H-M, Kim TS, Jo E-K. MiR-146 and miR-125 in the regulation of innate immunity and inflammation. BMB Rep. 2016;49:311\u20138.","journal-title":"BMB Rep"},{"key":"2265_CR82","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringd\u00e9n O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (London, England). 2008;371:1579\u201386.","journal-title":"Lancet (London, England)"},{"key":"2265_CR83","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1200\/JCO.2015.65.3642","volume":"34","author":"L Gao","year":"2016","unstructured":"Gao L, Zhang Y, Hu B, Liu J, Kong P, Lou S, Su Y, Yang T, Li H, Liu Y, Zhang C, Gao L, Zhu L, Wen Q, Wang P, Chen X, Zhong J, Zhang X. Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation. J Clin Oncol. 2016;34:2843\u201350.","journal-title":"J Clin Oncol"},{"key":"2265_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16:19\u201330.","journal-title":"World J Pediatr"},{"key":"2265_CR85","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009;27:1421\u201332.","journal-title":"Stem Cells"},{"key":"2265_CR86","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fimmu.2017.00526","volume":"8","author":"J Sharma","year":"2017","unstructured":"Sharma J, Hampton JM, Valiente GR, Wada T, Steigelman H, Young MC, Spurbeck RR, Blazek AD, B\u00f6sh S, Jarjour WN. Therapeutic development of mesenchymal stem cells or their extracellular vesicles to inhibit autoimmune-mediated inflammatory processes in systemic lupus erythematosus. Front Immunol. 2017;8:526.","journal-title":"Front Immunol"},{"key":"2265_CR87","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS, Sun L. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010;69:1423\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2265_CR88","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.patbio.2014.07.009","volume":"62","author":"D Shi","year":"2014","unstructured":"Shi D, Li X, Chen H, Che N, Zhou S, Lu Z, Shi S, Sun L. High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus. Pathol Biol. 2014;62:382\u201390.","journal-title":"Pathol Biol"},{"key":"2265_CR89","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1002\/art.38674","volume":"66","author":"D Wang","year":"2014","unstructured":"Wang D, Feng X, Lu L, Konkel JE, Zhang H, Chen Z, Li X, Gao X, Lu L, Shi S. A CD8 T cell\/indoleamine 2, 3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus. Arthritis Rheumatol. 2014;66:2234\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"2265_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0898-x","volume":"9","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Feng X. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus. Stem Cell Res Ther. 2018;9:1\u20136.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR91","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/art.27560","volume":"62","author":"F Schena","year":"2010","unstructured":"Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A. Interferon-\u03b3\u2013dependent inhibition of B cell activation by bone marrow\u2013derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 2010;62:2776\u201386.","journal-title":"Arthritis Rheum"},{"key":"2265_CR92","doi-asserted-by":"publisher","first-page":"132","DOI":"10.21037\/atm.2019.02.41","volume":"7","author":"X Tang","year":"2019","unstructured":"Tang X, Li W, Wen X, Zhang Z, Chen W, Yao G, Chen H, Wang D, Shi S, Sun L. Transplantation of dental tissue-derived mesenchymal stem cells ameliorates nephritis in lupus mice. Ann Transl Med. 2019;7:132.","journal-title":"Ann Transl Med"},{"key":"2265_CR93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0961203309348983","volume":"19","author":"F Carrion","year":"2010","unstructured":"Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, M\u00f6nckeberg G, Figueroa F. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus. 2010;19:317\u201322.","journal-title":"Lupus"},{"key":"2265_CR94","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","volume":"14","author":"D Wang","year":"2017","unstructured":"Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, Feng X, Sun L. The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14:423\u201331.","journal-title":"Cell Mol Immunol"},{"key":"2265_CR95","first-page":"24","volume":"8","author":"A Dulamea","year":"2015","unstructured":"Dulamea A. Mesenchymal stem cells in multiple sclerosis - translation to clinical trials. J Med Life. 2015;8:24\u20137.","journal-title":"J Med Life"},{"key":"2265_CR96","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fimmu.2019.00238","volume":"10","author":"M Abbasi-Kangevari","year":"2019","unstructured":"Abbasi-Kangevari M, Ghamari SH, Safaeinejad F, Bahrami S, Niknejad H. Potential therapeutic features of human amniotic mesenchymal stem cells in multiple sclerosis: immunomodulation, inflammation suppression, angiogenesis promotion, oxidative stress inhibition, neurogenesis induction, MMPs regulation, and remyelination stimulation. Front Immunol. 2019;10:238.","journal-title":"Front Immunol"},{"key":"2265_CR97","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s00018-019-03174-6","volume":"76","author":"L Muri","year":"2019","unstructured":"Muri L, Leppert D, Grandgirard D, Leib SL. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis. Cell Mol Life Sci. 2019;76:3097\u2013116.","journal-title":"Cell Mol Life Sci"},{"key":"2265_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01857","volume":"5","author":"LL Pinheiro","year":"2019","unstructured":"Pinheiro LL, de Lima AR, Martins DM, de Oliveira EHC, Souza MPC, de Carvalho Miranda CMF, Baleeiro Beltr\u00e3o-Braga PC, Russo FB, Pignatari GC, da Silva Filho E, Branco \u00c9. Mesenchymal stem cells in dogs with demyelinating leukoencephalitis as an experimental model of multiple sclerosis. Heliyon. 2019;5:e01857.","journal-title":"Heliyon"},{"key":"2265_CR99","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/glia.20841","volume":"57","author":"L Bai","year":"2009","unstructured":"Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57:1192\u2013203.","journal-title":"Glia"},{"key":"2265_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202590","volume":"13","author":"F Laso-Garc\u00eda","year":"2018","unstructured":"Laso-Garc\u00eda F, Ramos-Cejudo J, Carrillo-Salinas FJ, Otero-Ortega L, Feli\u00fa A, G\u00f3mez-de Frutos M, Mecha M, D\u00edez-Tejedor E, Guaza C, Guti\u00e9rrez-Fern\u00e1ndez M. Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis. PLoS One. 2018;13:e0202590.","journal-title":"PLoS One"},{"key":"2265_CR101","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0394632017722332","volume":"30","author":"T Soundara Rajan","year":"2017","unstructured":"Soundara Rajan T, Giacoppo S, Diomede F, Bramanti P, Trubiani O, Mazzon E. Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis. Int J Immunopathol Pharmacol. 2017;30:238\u201352.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2265_CR102","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-018-1433-7","volume":"16","author":"NH Riordan","year":"2018","unstructured":"Riordan NH, Morales I, Fern\u00e1ndez G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Paz Rodriguez J. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J Transl Med. 2018;16:57.","journal-title":"J Transl Med"},{"key":"2265_CR103","doi-asserted-by":"publisher","first-page":"e0195891","DOI":"10.1371\/journal.pone.0195891","volume":"13","author":"O Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez O, Izquierdo G, Fern\u00e1ndez V, Leyva L, Reyes V, Guerrero M, Le\u00f3n A, Arnaiz C, Navarro G, P\u00e1ramo MD, Cuesta A, Soria B, Hmadcha A, Pozo D, Fernandez-Montesinos R, Leal M, Ochotorena I, G\u00e1lvez P, Geniz MA, Bar\u00f3n FJ, Mata R, Medina C, Caparr\u00f3s-Escudero C, Cardesa A, Cuende N. Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I\/II safety and feasibility study. PLoS One. 2018;13:e0195891.","journal-title":"PLoS One"},{"key":"2265_CR104","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du M-Q, Luan S-L, Altmann DR, Thompson AJ. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 2012;11:150\u20136.","journal-title":"Lancet Neurol"},{"key":"2265_CR105","first-page":"576","volume":"39","author":"K Gohil","year":"2014","unstructured":"Gohil K, Carramusa B. Ulcerative colitis and Crohn\u2019s disease. P T. 2014;39:576\u20137.","journal-title":"P T"},{"key":"2265_CR106","doi-asserted-by":"publisher","first-page":"e01071","DOI":"10.1002\/cti2.1071","volume":"8","author":"R Faleiro","year":"2019","unstructured":"Faleiro R, Liu J, Karunarathne D, Edmundson A, Winterford C, Nguyen TH, Simms LA, Radford-Smith G, Wykes M. Crohn\u2019s disease is facilitated by a disturbance of programmed death-1 ligand 2 on blood dendritic cells. Clin Transl Immunol. 2019;8:e01071.","journal-title":"Clin Transl Immunol"},{"key":"2265_CR107","doi-asserted-by":"publisher","first-page":"38008","DOI":"10.18632\/oncotarget.16682","volume":"8","author":"F Mao","year":"2017","unstructured":"Mao F, Tu Q, Wang L, Chu F, Li X, Li HS, Xu W. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. Oncotarget. 2017;8:38008\u201321.","journal-title":"Oncotarget"},{"key":"2265_CR108","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1517\/14712598.2011.602967","volume":"11","author":"PJ Mannon","year":"2011","unstructured":"Mannon PJ. Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease. Expert Opin Biol Ther. 2011;11:1249\u201356.","journal-title":"Expert Opin Biol Ther"},{"key":"2265_CR109","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez MA, Gonzalez\u2013Rey E, Rico L, B\u00fcscher D, Delgado M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology. 2009;136:978\u201389.","journal-title":"Gastroenterology"},{"key":"2265_CR110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10620-016-4166-6","volume":"62","author":"M Xie","year":"2017","unstructured":"Xie M, Qin H, Luo Q, He X, He X, Lan P, Lian L. Comparison of adipose-derived and bone marrow mesenchymal stromal cells in a murine model of Crohn\u2019s disease. Dig Dis Sci. 2017;62:115\u201323.","journal-title":"Dig Dis Sci"},{"key":"2265_CR111","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.3748\/wjg.v26.i26.3750","volume":"26","author":"J-G Gao","year":"2020","unstructured":"Gao J-G, Yu M-S, Zhang M-M, Gu X-W, Ren Y, Zhou X-X, Chen D, Yan T-L, Li Y-M, Jin X. Adipose-derived mesenchymal stem cells alleviate TNBS-induced colitis in rats by influencing intestinal epithelial cell regeneration, Wnt signaling, and T cell immunity. World J Gastroenterol. 2020;26:3750.","journal-title":"World J Gastroenterol"},{"key":"2265_CR112","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/mi.2015.123","volume":"9","author":"J Cos\u00edn-Roger","year":"2016","unstructured":"Cos\u00edn-Roger J, Ortiz-Masi\u00e1 D, Calatayud S, Hern\u00e1ndez C, Esplugues JV, Barrachina MD. The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD. Mucosal Immunol. 2016;9:986\u201398.","journal-title":"Mucosal Immunol"},{"key":"2265_CR113","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.mayocp.2015.03.023","volume":"90","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R, Gallia A, Sgarella A, Kruzliak P, Gobbi PG, Corazza GR. Long-term follow-up of Crohn disease fistulas after local injections of bone marrow-derived Mesenchymal stem cells. Mayo Clin Proc. 2015;90:747\u201355.","journal-title":"Mayo Clin Proc"},{"key":"2265_CR114","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281\u201390.","journal-title":"Lancet"},{"key":"2265_CR115","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"GM Forbes","year":"2014","unstructured":"Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014;12:64\u201371.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2265_CR116","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1111\/trf.15311","volume":"59","author":"AP Vlaar","year":"2019","unstructured":"Vlaar AP, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, Bolton-Maggs P, Peters AL, Silliman CC, Kor DJ. A consensus redefinition of transfusion-related acute lung injury. Transfusion. 2019;59:2465\u201376.","journal-title":"Transfusion"},{"key":"2265_CR117","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1172\/JCI138136","volume":"130","author":"SJ Cleary","year":"2020","unstructured":"Cleary SJ, Kwaan N, Tian JJ, Calabrese DR, Mallavia B, Magnen M, Greenland JR, Urisman A, Singer JP, Hays SR, Kukreja J, Hay AM, Howie HL, Toy P, Lowell CA, Morrell CN, Zimring JC, Looney MR. Complement activation on endothelium initiates antibody-mediated acute lung injury. J Clin Invest. 2020;130:5909\u201323.","journal-title":"J Clin Invest"},{"key":"2265_CR118","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jaci.2017.08.017","volume":"141","author":"X Li","year":"2018","unstructured":"Li X, Michaeloudes C, Zhang Y, Wiegman CH, Adcock IM, Lian Q, Mak JCW, Bhavsar PK, Chung KF. Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways. J Allergy Clin Immunol. 2018;141:1634\u20131645.e1635.","journal-title":"J Allergy Clin Immunol"},{"key":"2265_CR119","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13287-018-0774-8","volume":"9","author":"M Khatri","year":"2018","unstructured":"Khatri M, Richardson LA, Meulia T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018;9:17.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR120","first-page":"1241","volume":"43","author":"L Li","year":"2019","unstructured":"Li L, Dong L, Zhang J, Gao F, Hui J, Yan J. Mesenchymal stem cells with downregulated hippo signaling attenuate lung injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome. Int J Mol Med. 2019;43:1241\u201352.","journal-title":"Int J Mol Med"},{"key":"2265_CR121","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1097\/CCM.0000000000002833","volume":"46","author":"JD Silva","year":"2018","unstructured":"Silva JD, Lopes-Pacheco M, Paz AHR, Cruz FF, Melo EB, de Oliveira MV, Xisto DG, Capelozzi VL, Morales MM, Pelosi P, Cirne-Lima E, Rocco PRM. Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Crit Care Med. 2018;46:e132\u201340.","journal-title":"Crit Care Med"},{"key":"2265_CR122","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1002\/jcp.25816","volume":"232","author":"L Pedrazza","year":"2017","unstructured":"Pedrazza L, Cunha AA, Luft C, Nunes NK, Schimitz F, Gassen RB, Breda RV, Donadio MV, de Souza Wyse AT, Pitrez PMC, Rosa JL, de Oliveira JR. Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation. J Cell Physiol. 2017;232:3552\u201364.","journal-title":"J Cell Physiol"},{"key":"2265_CR123","doi-asserted-by":"publisher","first-page":"111454","DOI":"10.1016\/j.yexcr.2019.05.035","volume":"383","author":"X Yi","year":"2019","unstructured":"Yi X, Wei X, Lv H, An Y, Li L, Lu P, Yang Y, Zhang Q, Yi H, Chen G. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. 2019;383:111454.","journal-title":"Exp Cell Res"},{"key":"2265_CR124","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcb.24377","volume":"114","author":"XJ Guan","year":"2013","unstructured":"Guan XJ, Song L, Han FF, Cui ZL, Chen X, Guo XJ, Xu WG. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem. 2013;114:323\u201335.","journal-title":"J Cell Biochem"},{"key":"2265_CR125","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3109\/14653241003745888","volume":"12","author":"G Zhen","year":"2010","unstructured":"Zhen G, Xue Z, Zhao J, Gu N, Tang Z, Xu Y, Zhang Z. Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy. 2010;12:605\u201314.","journal-title":"Cytotherapy"},{"key":"2265_CR126","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13287-018-0846-9","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, Yang Y, Guan Y, Du Z, Shao H. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 2018;9:110.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR127","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","volume":"197","author":"GR Willis","year":"2018","unstructured":"Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, Kwong A, Mitsialis SA, Kourembanas S. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am J Respir Crit Care Med. 2018;197:104\u201316.","journal-title":"Am J Respir Crit Care Med"},{"key":"2265_CR128","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1002\/jcp.26418","volume":"233","author":"GA Rubio","year":"2018","unstructured":"Rubio GA, Elliot SJ, Wikramanayake TC, Xia X, Pereira-Simon S, Thaller SR, Glinos GD, Jozic I, Hirt P, Pastar I, Tomic-Canic M, Glassberg MK. Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing. J Cell Physiol. 2018;233:5503\u201312.","journal-title":"J Cell Physiol"},{"key":"2265_CR129","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-015-0081-6","volume":"6","author":"YW Lan","year":"2015","unstructured":"Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, Kuo HP, Chong KY. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther. 2015;6:97.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR130","doi-asserted-by":"crossref","unstructured":"Xiang B, Chen L, Wang X, Zhao Y, Wang Y, Xiang C. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury. Int J Mol Sci. 2017:18;18.","DOI":"10.3390\/ijms18040689"},{"key":"2265_CR131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molimm.2019.02.017","volume":"109","author":"H Zhong","year":"2019","unstructured":"Zhong H, Fan XL, Fang SB, Lin YD, Wen W, Fu QL. Human pluripotent stem cell-derived mesenchymal stem cells prevent chronic allergic airway inflammation via TGF-\u03b21-Smad2\/Smad3 signaling pathway in mice. Mol Immunol. 2019;109:51\u20137.","journal-title":"Mol Immunol"},{"key":"2265_CR132","doi-asserted-by":"publisher","first-page":"45626","DOI":"10.18632\/oncotarget.17320","volume":"8","author":"FY Lee","year":"2017","unstructured":"Lee FY, Chen KH, Wallace CG, Sung PH, Sheu JJ, Chung SY, Chen YL, Lu HI, Ko SF, Sun CK, Chiang HJ, Chang HW, Lee MS, Yip HK. Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis. Oncotarget. 2017;8:45626\u201342.","journal-title":"Oncotarget"},{"key":"2265_CR133","first-page":"3283","volume":"19","author":"J Chen","year":"2019","unstructured":"Chen J, Si L, Zhou L, Deng Y. Role of bone marrow mesenchymal stem cells in the development of PQ-induced pulmonary fibrosis. Mol Med Rep. 2019;19:3283\u201390.","journal-title":"Mol Med Rep"},{"key":"2265_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196048","volume":"13","author":"G Moroncini","year":"2018","unstructured":"Moroncini G, Paolini C, Orlando F, Capelli C, Grieco A, Tonnini C, Agarbati S, Mondini E, Saccomanno S, Goteri G, Svegliati Baroni S, Provinciali M, Introna M, Del Papa N, Gabrielli A. Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice. PLoS One. 2018;13:e0196048.","journal-title":"PLoS One"},{"key":"2265_CR135","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/jcb.26268","volume":"119","author":"XP Han","year":"2018","unstructured":"Han XP, Zhang FQ, Tan XS, Liu L, Ma WX, Ou-Yang HF, Wu CG. EPO modified MSCs can inhibit asthmatic airway remodeling in an animal model. J Cell Biochem. 2018;119:1008\u201316.","journal-title":"J Cell Biochem"},{"key":"2265_CR136","first-page":"969","volume":"20","author":"F Liu","year":"2016","unstructured":"Liu F, Lin Q, Liu Z. A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models. Eur Rev Med Pharmacol Sci. 2016;20:969\u201382.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2265_CR137","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/sctm.18-0056","volume":"8","author":"SC Abreu","year":"2019","unstructured":"Abreu SC, Xisto DG, de Oliveira TB, Blanco NG, de Castro LL, Kitoko JZ, Olsen PC, Lopes-Pacheco M, Morales MM, Weiss DJ, Rocco PRM. Serum from asthmatic mice potentiates the therapeutic effects of mesenchymal stromal cells in experimental allergic asthma. Stem Cells Transl Med. 2019;8:301\u201312.","journal-title":"Stem Cells Transl Med"},{"key":"2265_CR138","first-page":"1731","volume":"95","author":"Z Jin","year":"2015","unstructured":"Jin Z, Wang Q, Bi H, Zhou K, He L, He X, Wu Q, Pan X. Effects and possible mechanisms of mesenchymal stem cell transplantation on emphysema in rats. Zhonghua Yi Xue Za Zhi. 2015;95:1731\u20135.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2265_CR139","first-page":"2258","volume":"98","author":"Q Chang","year":"2018","unstructured":"Chang Q, Tian X, Huo R, Liu D, Chen J, Wang X, Tian X. Therapeutic effect of human umbilical cord mesenchymal stem cells on airway remodeling in an asthma model of rat and its possible mechanism. Zhonghua Yi Xue Za Zhi. 2018;98:2258\u201363.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2265_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22217","volume":"32","author":"MG Soliman","year":"2018","unstructured":"Soliman MG, Mansour HA, Hassan WA, El-Sayed RA, Hassaan NA. Mesenchymal stem cells therapeutic potential alleviate lipopolysaccharide-induced acute lung injury in rat model. J Biochem Mol Toxicol. 2018;32:e22217.","journal-title":"J Biochem Mol Toxicol"},{"key":"2265_CR141","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/thoraxjnl-2011-201059","volume":"67","author":"GF Curley","year":"2012","unstructured":"Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O'Brien T, O'Toole D, Laffey JG. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax. 2012;67:496\u2013501.","journal-title":"Thorax"},{"key":"2265_CR142","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.scr.2016.05.005","volume":"17","author":"Y Moodley","year":"2016","unstructured":"Moodley Y, Sturm M, Shaw K, Shimbori C, Tan DB, Kolb M, Graham R. Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury. Stem Cell Res. 2016;17:25\u201331.","journal-title":"Stem Cell Res"},{"key":"2265_CR143","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/thoraxjnl-2013-204980","volume":"69","author":"S Asmussen","year":"2014","unstructured":"Asmussen S, Ito H, Traber DL, Lee JW, Cox RA, Hawkins HK, McAuley DF, McKenna DH, Traber LD, Zhuo H, Wilson J, Herndon DN, Prough DS, Liu KD, Matthay MA, Enkhbaatar P. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax. 2014;69:819\u201325.","journal-title":"Thorax"},{"key":"2265_CR144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"H Zhu","year":"2017","unstructured":"Zhu H, Xiong Y, Xia Y, Zhang R, Tian D, Wang T, Dai J, Wang L, Yao H, Jiang H. Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep"},{"key":"2265_CR145","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yexcr.2017.12.021","volume":"363","author":"Y-m Du","year":"2018","unstructured":"Du Y-m, Zhuansun Y-x, Chen R, Lin L, Lin Y, Li J-g. Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma. Exp Cell Res. 2018;363:114\u201320.","journal-title":"Exp Cell Res"},{"key":"2265_CR146","first-page":"731","volume":"29","author":"L Li","year":"2017","unstructured":"Li L, Dong L, Hui J, Gao F, Wang Q, Yang L, Zhang J, Yan J. Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29:731\u20137.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2265_CR147","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.18632\/aging.103025","volume":"12","author":"X Chen","year":"2020","unstructured":"Chen X, Xu C-X, Liang H, Xi Z, Pan J, Yang Y, Sun Q, Yang G, Sun Y, Bian L. Bone marrow mesenchymal stem cells transplantation alleviates brain injury after intracerebral hemorrhage in mice through the Hippo signaling pathway. Aging. 2020;12:6306\u201323.","journal-title":"Aging"},{"key":"2265_CR148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.12659\/MSM.911398","volume":"25","author":"T Zhou","year":"2019","unstructured":"Zhou T, Chen YL. The functional mechanisms of miR-30b-5p in acute lung injury in children. Med Sci Monit. 2019;25:40\u201351.","journal-title":"Med Sci Monit"},{"key":"2265_CR149","first-page":"80","volume":"26","author":"L Fen","year":"2014","unstructured":"Fen L, Rong J, Zhenguo Z, Ning Z, Liang X, Cheng N, Kejian Q. The expression changes in microRNA-132 in the lipopolysaccharide-induced inflammation of rat alveolar macrophages. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:80\u20133.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2265_CR150","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759\u201365.","journal-title":"Nat Med"},{"key":"2265_CR151","first-page":"166","volume":"24","author":"Z Zeng","year":"2012","unstructured":"Zeng Z, Gong H, Li Y, Nie Z, Jie K, Zhan Y, Nie C, Liu F, Ding C, Shao Q. Effect of Shenfu injection on expression of lipopolysaccharide--induced microRNA-146a in alveolar macrophages. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24:166\u20139.","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2265_CR152","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","volume":"25","author":"S Paliwal","year":"2018","unstructured":"Paliwal S, Chaudhuri R, Agrawal A, Mohanty S. Regenerative abilities of mesenchymal stem cells through mitochondrial transfer. J Biomed Sci. 2018;25:31.","journal-title":"J Biomed Sci"},{"key":"2265_CR153","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","volume":"3","author":"JG Wilson","year":"2015","unstructured":"Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3:24\u201332.","journal-title":"Lancet Respir Med"},{"key":"2265_CR154","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"TP Velavan","year":"2020","unstructured":"Velavan TP, Meyer CG. The COVID-19 epidemic. Tropical Med Int Health. 2020;25:278.","journal-title":"Tropical Med Int Health"},{"key":"2265_CR155","doi-asserted-by":"crossref","unstructured":"Apolone G, Montomoli E, Manenti A, Boeri M, Sabia F, Hyseni I, Mazzini L, Martinuzzi D, Cantone L, Milanese G. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori J. 2020:0300891620974755.","DOI":"10.1177\/0300891620974755"},{"key":"2265_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03120-0","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Yang D. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24:1\u201310.","journal-title":"Crit Care"},{"key":"2265_CR157","doi-asserted-by":"crossref","unstructured":"Sharquie IK. BCG is a good immunotherapeutic agent for viral and autoimmune diseases: is it a new weapon against coronavirus (COVID-19)? Electron J Gen Med. 2020:17;17.","DOI":"10.29333\/ejgm\/7892"},{"key":"2265_CR158","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.","journal-title":"Front Immunol"},{"key":"2265_CR159","first-page":"11","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11.","journal-title":"Mil Med Res"},{"key":"2265_CR160","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13287-020-01849-7","volume":"11","author":"M Kavianpour","year":"2020","unstructured":"Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther. 2020;11:404.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR161","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Transplantation of ACE2(\u2212) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11:216\u201328.","journal-title":"Aging Dis"},{"key":"2265_CR162","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","volume":"11","author":"L Shu","year":"2020","unstructured":"Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, Ji N, Zheng Y, Chen X, Shi L, Wu M, Deng K, Wei J, Wang X, Cao Y, Yan J, Feng G. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2020;11:361.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR163","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021429","volume":"99","author":"B Liang","year":"2020","unstructured":"Liang B, Chen J, Li T, Wu H, Yang W, Li Y, Li J, Yu C, Nie F, Ma Z, Yang M, Xiao M, Nie P, Gao Y, Qian C, Hu M. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report. Medicine (Baltimore). 2020;99:e21429.","journal-title":"Medicine (Baltimore)"},{"key":"2265_CR164","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13287-020-01725-4","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ding J, Ren S, Wang W, Yang Y, Li S, Meng M, Wu T, Liu D, Tian S, Tian H, Chen S, Zhou C. Intravenous infusion of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell Res Ther. 2020;11:207.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR165","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/scd.2020.0080","volume":"29","author":"V Sengupta","year":"2020","unstructured":"Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev. 2020;29:747\u201354.","journal-title":"Stem Cells Dev"},{"key":"2265_CR166","doi-asserted-by":"publisher","first-page":"118493","DOI":"10.1016\/j.lfs.2020.118493","volume":"262","author":"S Sadeghi","year":"2020","unstructured":"Sadeghi S, Soudi S, Shafiee A, Hashemi SM. Mesenchymal stem cell therapies for COVID-19: current status and mechanism of action. Life Sci. 2020;262:118493.","journal-title":"Life Sci"},{"key":"2265_CR167","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7150\/thno.17133","volume":"7","author":"S-C Tao","year":"2017","unstructured":"Tao S-C, Yuan T, Zhang Y-L, Yin W-J, Guo S-C, Zhang C-Q. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7:180.","journal-title":"Theranostics"},{"key":"2265_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188072","volume":"12","author":"P Fernandez-Pernas","year":"2017","unstructured":"Fernandez-Pernas P, Rodr\u00edguez-Lesende I, de la Fuente A, Mateos J, Fuentes I, De Toro J, Blanco FJ, Arufe MC. CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model. PLoS One. 2017;12:e0188072.","journal-title":"PLoS One"},{"key":"2265_CR169","doi-asserted-by":"publisher","first-page":"218","DOI":"10.22203\/eCM.v036a16","volume":"36","author":"S Khatab","year":"2018","unstructured":"Khatab S, van Osch GJ, Kops N, Bastiaansen-Jenniskens YM, Bos PK, Verhaar JA, Bernsen MR, van Buul GM. Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model. Eur Cells Mater. 2018;36:218\u201330.","journal-title":"Eur Cells Mater"},{"key":"2265_CR170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193086","volume":"13","author":"K Lee","year":"2018","unstructured":"Lee K, Park N, Jung H, Rim YA, Nam Y, Lee J, Park SH, Ju JH. Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist. PLoS One. 2018;13:e0193086.","journal-title":"PLoS One"},{"key":"2265_CR171","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/08916934.2018.1428956","volume":"51","author":"SS Abd-Elhalem","year":"2018","unstructured":"Abd-Elhalem SS, Haggag NZ, El-Shinnawy NA. Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis. Autoimmunity. 2018;51:25\u201334.","journal-title":"Autoimmunity"},{"key":"2265_CR172","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13287-018-1071-2","volume":"9","author":"P Neybecker","year":"2018","unstructured":"Neybecker P, Henrionnet C, Pape E, Mainard D, Galois L, Loeuille D, Gillet P, Pinzano A. In vitro and in vivo potentialities for cartilage repair from human advanced knee osteoarthritis synovial fluid-derived mesenchymal stem cells. Stem Cell Res Ther. 2018;9:329.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR173","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13018-016-0342-9","volume":"11","author":"S Yun","year":"2016","unstructured":"Yun S, Ku SK, Kwon YS. Adipose-derived mesenchymal stem cells and platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis in Beagle dogs. J Orthop Surg Res. 2016;11:9.","journal-title":"J Orthop Surg Res"},{"key":"2265_CR174","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.1038\/s41598-019-50435-2","volume":"9","author":"H Kim","year":"2019","unstructured":"Kim H, Yang G, Park J, Choi J, Kang E, Lee BK. Therapeutic effect of mesenchymal stem cells derived from human umbilical cord in rabbit temporomandibular joint model of osteoarthritis. Sci Rep. 2019;9:13854.","journal-title":"Sci Rep"},{"key":"2265_CR175","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","volume":"201","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wang H, Xia Y, Yan F, Lu Y. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol (Baltimore, Md. : 1950). 2018;201:2472\u201382.","journal-title":"J Immunol (Baltimore, Md. : 1950)"},{"key":"2265_CR176","doi-asserted-by":"crossref","unstructured":"Ichiseki T, Shimazaki M, Ueda Y, Ueda S, Tsuchiya M, Souma D, Kaneuji A, Kawahara N. Intraarticularly-injected mesenchymal stem cells stimulate anti-inflammatory molecules and inhibit pain related protein and chondrolytic enzymes in a monoiodoacetate-induced rat arthritis model. Int J Mol Sci. 2018:19;19.","DOI":"10.3390\/ijms19010203"},{"key":"2265_CR177","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/term.2916","volume":"13","author":"W Chen","year":"2019","unstructured":"Chen W, Sun Y, Gu X, Hao Y, Liu X, Lin J, Chen J, Chen S. Conditioned medium of mesenchymal stem cells delays osteoarthritis progression in a rat model by protecting subchondral bone, maintaining matrix homeostasis, and enhancing autophagy. J Tissue Eng Regen Med. 2019;13:1618\u201328.","journal-title":"J Tissue Eng Regen Med"},{"key":"2265_CR178","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/cells8080823","volume":"8","author":"SM Haikal","year":"2019","unstructured":"Haikal SM, Abdeltawab NF, Rashed LA, Abd El-Galil TI, Elmalt HA, Amin MA. Combination therapy of mesenchymal stromal cells and interleukin-4 attenuates rheumatoid arthritis in a collagen-induced murine model. Cells. 2019;8:823.","journal-title":"Cells"},{"key":"2265_CR179","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1080\/15384101.2018.1526603","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lin L, Zou R, Wen C, Wang Z, Lin F. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1\/miR-206\/GIT1 axis in osteoarthritis. Cell Cycle. 2018;17:2411\u201322.","journal-title":"Cell Cycle"},{"key":"2265_CR180","doi-asserted-by":"publisher","first-page":"8459281","DOI":"10.1155\/2019\/8459281","volume":"2019","author":"F Li","year":"2019","unstructured":"Li F, Li X, Liu G, Gao C, Li X. Bone marrow mesenchymal stem cells decrease the expression of RANKL in collagen-induced arthritis rats via reducing the levels of IL-22. J Immunol Res. 2019;2019:8459281.","journal-title":"J Immunol Res"},{"key":"2265_CR181","doi-asserted-by":"publisher","first-page":"105687","DOI":"10.1016\/j.intimp.2019.105687","volume":"74","author":"D Ma","year":"2019","unstructured":"Ma D, Xu K, Zhang G, Liu Y, Gao J, Tian M, Wei C, Li J, Zhang L. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol. 2019;74:105687.","journal-title":"Int Immunopharmacol"},{"key":"2265_CR182","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.knee.2010.03.001","volume":"18","author":"FS Toghraie","year":"2011","unstructured":"Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, Dehghani S, Ghaderi A. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee. 2011;18:71\u20135.","journal-title":"Knee"},{"key":"2265_CR183","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13287-016-0285-4","volume":"7","author":"CC Wu","year":"2016","unstructured":"Wu CC, Liu FL, Sytwu HK, Tsai CY, Chang DM. CD146+ mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther. 2016;7:23.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR184","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.03.022","volume":"206","author":"J Wu","year":"2019","unstructured":"Wu J, Kuang L, Chen C, Yang J, Zeng WN, Li T, Chen H, Huang S, Fu Z, Li J, Liu R, Ni Z, Chen L, Yang L. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. 2019;206:87\u2013100.","journal-title":"Biomaterials"},{"key":"2265_CR185","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/jor.20933","volume":"27","author":"DD Frisbie","year":"2009","unstructured":"Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res. 2009;27:1675\u201380.","journal-title":"J Orthop Res"},{"key":"2265_CR186","doi-asserted-by":"publisher","first-page":"28915","DOI":"10.1038\/srep28915","volume":"6","author":"X Yan","year":"2016","unstructured":"Yan X, Cen Y, Wang Q. Mesenchymal stem cells alleviate experimental rheumatoid arthritis through microRNA-regulated I\u03baB expression. Sci Rep. 2016;6:28915.","journal-title":"Sci Rep"},{"key":"2265_CR187","first-page":"211","volume":"47","author":"YP Cui","year":"2015","unstructured":"Cui YP, Cao YP, Liu H, Yang X, Meng ZC, Wang R. Bone marrow mesenchymal stem cells in Sprague-Dawley rat model of osteoarthritis. Beijing Da Xue Xue Bao Yi Xue Ban. 2015;47:211\u20138.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"2265_CR188","doi-asserted-by":"publisher","first-page":"523","DOI":"10.5966\/sctm.2014-0200","volume":"4","author":"Q Xia","year":"2015","unstructured":"Xia Q, Zhu S, Wu Y, Wang J, Cai Y, Chen P, Li J, Heng BC, Ouyang HW, Lu P. Intra-articular transplantation of atsttrin-transduced mesenchymal stem cells ameliorate osteoarthritis development. Stem Cells Transl Med. 2015;4:523\u201331.","journal-title":"Stem Cells Transl Med"},{"key":"2265_CR189","doi-asserted-by":"publisher","first-page":"12777","DOI":"10.1038\/srep12777","volume":"5","author":"R Liu","year":"2015","unstructured":"Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, Feng X, Gao X, Shi S, Chen W, Sun L. Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep. 2015;5:12777.","journal-title":"Sci Rep"},{"key":"2265_CR190","doi-asserted-by":"publisher","first-page":"19","DOI":"10.14715\/cmb\/2018.64.2.5","volume":"64","author":"V Nazemian","year":"2018","unstructured":"Nazemian V, Manaheji H, Sharifi AM, Zaringhalam J. Long term treatment by mesenchymal stem cells conditioned medium modulates cellular, molecular and behavioral aspects of adjuvant-induced arthritis. Cell Mol Biol (Noisy-le-Grand, France). 2018;64:19\u201326.","journal-title":"Cell Mol Biol (Noisy-le-Grand, France)"},{"key":"2265_CR191","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10103-018-2466-0","volume":"33","author":"TG Stancker","year":"2018","unstructured":"Stancker TG, Vieira SS, Serra AJ, do Nascimento Lima R, Feliciano RDS, Silva JA Jr, Santos SAD, Vieira MADS, Sim\u00f5es MCB, Leal-Junior EC, de Tarso Camillo de Carvalho P. Can photobiomodulation associated with implantation of mesenchymal adipose-derived stem cells attenuate the expression of MMPs and decrease degradation of type II collagen in an experimental model of osteoarthritis? Lasers Med Sci. 2018;33:1073\u201384.","journal-title":"Lasers Med Sci"},{"key":"2265_CR192","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/ten.tec.2008.0569","volume":"15","author":"B Grigolo","year":"2009","unstructured":"Grigolo B, Lisignoli G, Desando G, Cavallo C, Marconi E, Tschon M, Giavaresi G, Fini M, Giardino R, Facchini A. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit, tissue engineering. Part C Methods. 2009;15:647\u201358.","journal-title":"Part C Methods"},{"key":"2265_CR193","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00264-020-04584-z","volume":"45","author":"XD Wang","year":"2021","unstructured":"Wang XD, Wan XC, Liu AF, Li R, Wei Q. Effects of umbilical cord mesenchymal stem cells loaded with graphene oxide granular lubrication on cytokine levels in animal models of knee osteoarthritis. Int Orthop. 2021;45:381\u201390.","journal-title":"Int Orthop"},{"key":"2265_CR194","first-page":"1271","volume":"33","author":"WJ Tseng","year":"2018","unstructured":"Tseng WJ, Huang S-W, Fang C-H, Hsu L-T, Chen C-Y, Shen H-H, Chang J, Sun J-S, Lin F-H. Treatment of osteoarthritis with collagen-based scaffold: a porcine animal model with xenograft mesenchymal stem cells. Histol Histopathol. 2018;33:1271\u201386.","journal-title":"Histol Histopathol"},{"key":"2265_CR195","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrrheum.2017.182","volume":"13","author":"D McGonagle","year":"2017","unstructured":"McGonagle D, Baboolal TG, Jones E. Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis. Nat Rev Rheumatol. 2017;13:719\u201330.","journal-title":"Nat Rev Rheumatol"},{"key":"2265_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0632-0","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yu D, Liu Z, Zhou F, Dai J, Wu B, Zhou J, Heng BC, Zou XH, Ouyang H. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 2017;8:1\u201313.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR197","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13075-016-0979-0","volume":"18","author":"E Gonzalo-Gil","year":"2016","unstructured":"Gonzalo-Gil E, P\u00e9rez-Lorenzo MJ, Galindo M, D\u00edaz de la Guardia R, L\u00f3pez-Mill\u00e1n B, Bueno C, Men\u00e9ndez P, Pablos JL, Criado G. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase. Arthritis Res Ther. 2016;18:77.","journal-title":"Arthritis Res Ther"},{"key":"2265_CR198","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0049-0172(03)00134-3","volume":"33","author":"J Martel-Pelletier","year":"2003","unstructured":"Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum. 2003;33:155\u201367.","journal-title":"Semin Arthritis Rheum"},{"key":"2265_CR199","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/jor.22650","volume":"32","author":"GM van Buul","year":"2014","unstructured":"van Buul GM, Siebelt M, Leijs MJ, Bos PK, Waarsing JH, Kops N, Weinans H, Verhaar JA, Bernsen MR, van Osch GJ. Mesenchymal stem cells reduce pain but not degenerative changes in a mono-iodoacetate rat model of osteoarthritis. J Orthop Res. 2014;32:1167\u201374.","journal-title":"J Orthop Res"},{"key":"2265_CR200","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-016-1160-5","volume":"18","author":"Y Gu","year":"2016","unstructured":"Gu Y, Shi S. Transplantation of gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis. Arthritis Res Ther. 2016;18:262.","journal-title":"Arthritis Res Ther"},{"key":"2265_CR201","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.4049\/jimmunol.1500332","volume":"195","author":"MG Garimella","year":"2015","unstructured":"Garimella MG, Kour S, Piprode V, Mittal M, Kumar A, Rani L, Pote ST, Mishra GC, Chattopadhyay N, Wani MR. Adipose-derived mesenchymal stem cells prevent systemic bone loss in collagen-induced arthritis. J Immunol (Baltimore, Md. : 1950). 2015;195:5136\u201348.","journal-title":"J Immunol (Baltimore, Md. : 1950)"},{"key":"2265_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.442","volume":"7","author":"TH Shin","year":"2016","unstructured":"Shin TH, Kim HS, Kang TW, Lee BC, Lee HY, Kim YJ, Shin JH, Seo Y, Won Choi S, Lee S, Shin K, Seo KW, Kang KS. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 2016;7:e2524.","journal-title":"Cell Death Dis"},{"key":"2265_CR203","first-page":"1415","volume":"7","author":"F Song","year":"2014","unstructured":"Song F, Tang J, Geng R, Hu H, Zhu C, Cui W, Fan W. Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model. Int J Clin Exp Pathol. 2014;7:1415.","journal-title":"Int J Clin Exp Pathol"},{"key":"2265_CR204","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.arthro.2012.11.017","volume":"29","author":"Y-G Koh","year":"2013","unstructured":"Koh Y-G, Jo S-B, Kwon O-R, Suh D-S, Lee S-W, Park S-H, Choi Y-J. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthrosc J Arthrosc Relat Surg. 2013;29:748\u201355.","journal-title":"Arthrosc J Arthrosc Relat Surg"},{"key":"2265_CR205","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1042\/BJ20151072","volume":"473","author":"SS Apte","year":"2016","unstructured":"Apte SS. Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis. Biochem J. 2016;473:e1\u20134.","journal-title":"Biochem J"},{"key":"2265_CR206","doi-asserted-by":"publisher","first-page":"32705","DOI":"10.1038\/srep32705","volume":"6","author":"L Xu","year":"2016","unstructured":"Xu L, Wu Y, Xiong Z, Zhou Y, Ye Z, Tan WS. Mesenchymal stem cells reshape and provoke proliferation of articular chondrocytes by paracrine secretion. Sci Rep. 2016;6:32705.","journal-title":"Sci Rep"},{"key":"2265_CR207","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/ar148","volume":"3","author":"LJ Sandell","year":"2001","unstructured":"Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 2001;3:107\u201313.","journal-title":"Arthritis Res"},{"key":"2265_CR208","doi-asserted-by":"publisher","first-page":"105946","DOI":"10.1016\/j.intimp.2019.105946","volume":"78","author":"Z Jin","year":"2020","unstructured":"Jin Z, Ren J, Qi S. Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2. Int Immunopharmacol. 2020;78:105946.","journal-title":"Int Immunopharmacol"},{"key":"2265_CR209","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13287-017-0632-0","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yu D, Liu Z, Zhou F, Dai J, Wu B, Zhou J, Heng BC, Zou XH, Ouyang H, Liu H. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 2017;8:189.","journal-title":"Stem Cell Res Ther"},{"key":"2265_CR210","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/rme-2017-0152","volume":"13","author":"Y Song","year":"2018","unstructured":"Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, Lu L, Bao C. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med. 2018;13:295\u2013307.","journal-title":"Regen Med"},{"key":"2265_CR211","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/sctm.18-0122","volume":"8","author":"WS Lee","year":"2019","unstructured":"Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med. 2019;8:504\u201311.","journal-title":"Stem Cells Transl Med"},{"key":"2265_CR212","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"CH Jo","year":"2014","unstructured":"Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS, Shin IS. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32:1254\u201366.","journal-title":"Stem Cells"},{"key":"2265_CR213","doi-asserted-by":"crossref","unstructured":"Tang CH. Research of pathogenesis and novel therapeutics in arthritis. Int J Mol Sci. 2019;20","DOI":"10.3390\/ijms20071646"},{"key":"2265_CR214","volume-title":"Multidisciplinary Digital Publishing Institute","author":"C-H Tang","year":"2020","unstructured":"Tang C-H. Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0. In: Multidisciplinary Digital Publishing Institute; 2020."},{"key":"2265_CR215","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2019.00266","volume":"10","author":"CL Ross","year":"2019","unstructured":"Ross CL, Ang DC, Almeida-Porada G. Targeting mesenchymal stromal cells\/pericytes (MSCs) with pulsed electromagnetic field (PEMF) has the potential to treat rheumatoid arthritis. Front Immunol. 2019;10:266.","journal-title":"Front Immunol"},{"key":"2265_CR216","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2019.00018","volume":"10","author":"JP Miranda","year":"2019","unstructured":"Miranda JP, Cam\u00f5es SP, Gaspar MM, Rodrigues JS, Carvalheiro M, B\u00e1rcia RN, Cruz P, Cruz H, Sim\u00f5es S, Santos JM. The secretome derived from 3D-cultured umbilical cord tissue MSCs counteracts manifestations typifying rheumatoid arthritis. Front Immunol. 2019;10:18.","journal-title":"Front Immunol"},{"key":"2265_CR217","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13075-017-1505-8","volume":"20","author":"K Chowdhury","year":"2018","unstructured":"Chowdhury K, Kumar U, Das S, Chaudhuri J, Kumar P, Kanjilal M, Ghosh P, Sircar G, Basyal RK, Kanga U, Bandyopadhaya S, Mitra DK. Synovial IL-9 facilitates neutrophil survival, function and differentiation of Th17 cells in rheumatoid arthritis. Arthritis Res Ther. 2018;20:18.","journal-title":"Arthritis Res Ther"},{"key":"2265_CR218","doi-asserted-by":"publisher","first-page":"105985","DOI":"10.1016\/j.intimp.2019.105985","volume":"78","author":"J Zheng","year":"2020","unstructured":"Zheng J, Zhu L, Iok In I, Chen Y, Jia N, Zhu W. Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis. Int Immunopharmacol. 2020;78:105985.","journal-title":"Int Immunopharmacol"},{"key":"2265_CR219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161306","volume":"11","author":"P Dey","year":"2016","unstructured":"Dey P, Panga V, Raghunathan S. A cytokine signalling network for the regulation of inducible nitric oxide synthase expression in rheumatoid arthritis. PLoS One. 2016;11:e0161306.","journal-title":"PLoS One"},{"key":"2265_CR220","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1566523220666200916120708","volume":"20","author":"F Tavasolian","year":"2020","unstructured":"Tavasolian F, Hosseini AZ, Soudi S, Naderi M. miRNA-146a improves immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr Gene Ther. 2020;20:297\u2013312.","journal-title":"Curr Gene Ther"},{"key":"2265_CR221","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/sctm.18-0031","volume":"7","author":"EH Park","year":"2018","unstructured":"Park EH, Lim HS, Lee S, Roh K, Seo KW, Kang KS, Shin K. Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase Ia clinical trial. Stem Cells Transl Med. 2018;7:636\u201342.","journal-title":"Stem Cells Transl Med"},{"key":"2265_CR222","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R, Carre\u00f1o L, Alonso A, Marsal S, Blanco F, Mart\u00ednez-Taboada VM, Taylor P, Mart\u00edn-Mart\u00edn C, DelaRosa O, Tagarro I, D\u00edaz-Gonz\u00e1lez F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis. 2017;76:196\u2013202.","journal-title":"Ann Rheum Dis"},{"key":"2265_CR223","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcyt.2017.12.009","volume":"20","author":"S Shadmanfar","year":"2018","unstructured":"Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S, Kakroodi FA, Bolurieh T, Hosseini SE, Chehrazi M, Niknejadi M, Baharvand H, Gharibdoost F, Aghdami N. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: results of a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy. 2018;20:499\u2013506.","journal-title":"Cytotherapy"},{"key":"2265_CR224","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","volume":"65","author":"D Rubio","year":"2005","unstructured":"Rubio D, Garcia-Castro J, Mart\u00edn MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035\u20139.","journal-title":"Cancer Res"},{"key":"2265_CR225","doi-asserted-by":"crossref","unstructured":"Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019:8;8.","DOI":"10.3390\/cells8070727"}],"updated-by":[{"DOI":"10.1186\/s13287-024-03733-0","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"record-id":"68064"},{"DOI":"10.1186\/s13287-024-03733-0","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000}}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02265-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02265-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02265-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T02:08:27Z","timestamp":1713751707000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02265-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":225,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2265"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02265-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13287-024-03733-0","URL":"https:\/\/doi.org\/10.1186\/s13287-024-03733-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}